세계의 정밀 정신의학 시장 보고서(2025년)

Precision psychiatry is a data driven approach that integrates genetic, neurobiological, behavioral, and environmental information to understand individual disease mechanisms. Its primary goal is to improve diagnostic accuracy, guide personalized treatment, and enhance outcomes by minimizing trial and error in prescribing. It also supports preventive strategies through personalized risk assessment and continuous monitoring.

The main therapeutic approaches in precision psychiatry include pharmacotherapy, psychotherapy, neurostimulation, digital therapeutics, and combination therapies. Pharmacotherapy in precision psychiatry refers to the use of personalized medication plans based on an individual's genetic, biochemical, and clinical profile to manage mental health disorders. It employs various technologies such as genetic testing, biomarker analysis, brain imaging techniques, wearable devices, and artificial intelligence and machine learning solutions, and is indicated for conditions including depression, anxiety disorders, bipolar disorder, schizophrenia, and post traumatic stress disorder (PTSD). It is applied in diagnosis, treatment, and research, serving end users such as clinics, hospitals, research institutes, pharmaceutical companies, and home care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The precision psychiatry market research report is one of a series of new reports from The Business Research Company that provides precision psychiatry market statistics, including precision psychiatry industry global market size, regional shares, competitors with a precision psychiatry market share, detailed precision psychiatry market segments, market trends and opportunities, and any further data you may need to thrive in the precision psychiatry industry. This precision psychiatry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision psychiatry market size has grown rapidly in recent years. It will grow from $4.34 billion in 2024 to $4.99 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to rising adoption of digital health tools, growing investment in psychiatric research, expansion of neuroimaging facilities, increasing focus on personalized treatment, and rising demand for remote monitoring solutions.

The precision psychiatry market size is expected to see rapid growth in the next few years. It will grow to $8.58 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing adoption of wearable biosensors, growing collaborations between biotech and healthcare providers, expansion of telepsychiatry platforms, rising funding for precision psychiatry startups, and increasing use of genetic testing in mental health assessment. Major trends in the forecast period include technological advancements in digital therapeutics, developments in neuroimaging and biomarker analysis, investment in research and development of personalized psychiatric treatments, innovation in cognitive assessment tools, and technological progress in remote patient monitoring.

The increasing prevalence of mental health disorders is expected to drive the growth of the precision psychiatry market in the coming years. Mental health disorders encompass a wide range of conditions, including depression, anxiety, and bipolar disorder, which impact mood, thinking, and behavior. The rise in mental health disorders is attributed to growing psychological distress from social, economic, and environmental pressures, along with improved screening and public awareness that contribute to higher diagnosis rates. Precision psychiatry addresses these disorders by providing data-driven, personalized treatment strategies that enhance diagnostic accuracy and therapeutic outcomes. For instance, in November 2023, according to NHS England, the UK based publicly funded national health authority, the rate of probable mental disorders among individuals aged 20 to 23 increased from 18.7 percent in 2022 to 21.6 percent in 2023. Therefore, the growing prevalence of mental health disorders is driving the expansion of the precision psychiatry market.

Major companies in the precision psychiatry market are developing new therapies such as prescription digital therapeutics to enable personalized, data-driven treatment for psychiatric conditions. A prescription digital therapeutic is a clinician-prescribed, software-based medical intervention that delivers evidence-based behavioral therapy modules through a mobile device to improve symptom management and treatment adherence. For example, in August 2024, Otsuka Precision Health Inc., a US based precision health subsidiary of Otsuka Holdings, and Click Therapeutics Inc., a US based digital therapeutics company, launched Rejoyn, the first prescription digital therapeutic cleared by the United States Food and Drug Administration (FDA) for adjunctive treatment of major depressive disorder symptoms. The product provides a six-week cognitive-emotional training program combining the emotional faces memory task with cognitive behavioral therapy based skill modules and supports digital prescribing, patient engagement, and remote monitoring. The launch of Rejoyn represents a key milestone in precision psychiatry, demonstrating how digital therapeutics can complement pharmacological treatments to deliver personalized care. It also supports broader adoption of software-based interventions that integrate real-time patient data to optimize treatment outcomes and adherence.

In January 2025, Johnson and Johnson, a US based pharmaceutical company, acquired Intra-Cellular Therapies Inc. for approximately $14.6 billion. Through this acquisition, Johnson and Johnson aims to expand its portfolio of innovative psychiatric therapies and leverage Intra-Cellular's expertise in mechanism-based drug development for central nervous system disorders. Intra-Cellular Therapies Inc. is a US based company focused on developing targeted neuropsychiatric therapies aligned with precision psychiatry.

Major companies operating in the precision psychiatry market are Johnson & Johnson, F. Hoffmann-La Roche Ltd, Pfizer Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Eli Lilly and Company, Otsuka Pharmaceutical Company Limited, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Illumina Inc., ARUP Laboratories Inc., Sumitomo Dainippon Pharma Company Limited, QIAGEN N.V., Neurocrine Biosciences Inc., Tempus Labs Inc., Myriad Genetics Inc., MedGenome Labs Ltd., Genomind Inc., STALICLA SA

North America was the largest region in the precision psychiatry market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in precision psychiatry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the precision psychiatry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision psychiatry market includes revenues earned by entities through psychiatric assessment, personalized treatment planning, remote monitoring, data analytics, and clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Psychiatry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision psychiatry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision psychiatry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision psychiatry market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapeutic Approaches: Pharmacotherapy; Psychotherapy; Neurostimulation; Digital Therapeutics; Combination Therapies
• 2) By Technology: Genetic Testing; Biomarker Analysis; Brain Imaging Techniques; Wearable Devices; Artificial Intelligence And Machine Learning Solutions
• 3) By Disorders: Depression; Anxiety Disorders; Bipolar Disorder; Schizophrenia; Post-Traumatic Stress Disorder (PTSD)
• 4) By Application: Diagnosis; Treatment; Research
• 5) By End User: Clinics; Hospitals; Research Institutes; Pharmaceutical Companies; Home Care Settings
• Subsegments:
• 1) By Pharmacotherapy: Antidepressant Medications; Antipsychotic Medications; Mood Stabilizers; Anxiolytic Medications; Stimulant Medications
• 2) By Psychotherapy: Cognitive Behavioral Therapy; Interpersonal Therapy; Psychodynamic Therapy; Dialectical Behavior Therapy; Mindfulness-Based Therapy
• 3) By Neurostimulation: Transcranial Magnetic Stimulation; Electroconvulsive Therapy; Vagus Nerve Stimulation; Deep Brain Stimulation; Transcranial Direct Current Stimulation
• 4) By Digital Therapeutics: Mobile Application-Based Therapy; Virtual Reality Therapy; Web-Based Cognitive Behavioral Programs; Remote Patient Monitoring Tools; Artificial Intelligence-Guided Interventions
• 5) By Combination Therapies: Pharmacotherapy And Psychotherapy Combination; Pharmacotherapy And Neurostimulation Combination; Pharmacotherapy And Digital Therapeutics Combination; Psychotherapy And Neurostimulation Combination; Multimodal Precision Treatment Programs
• Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd; Pfizer Inc.; AbbVie Inc.; AstraZeneca plc; Novartis AG; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Eli Lilly and Company; Otsuka Pharmaceutical Company Limited; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Illumina Inc.; ARUP Laboratories Inc.; Sumitomo Dainippon Pharma Company Limited; QIAGEN N.V.; Neurocrine Biosciences Inc.; Tempus Labs Inc.; Myriad Genetics Inc.; MedGenome Labs Ltd.; Genomind Inc.; STALICLA SA
• Countries:

Table of Contents

1. Executive Summary

2. Precision Psychiatry Market Characteristics

3. Precision Psychiatry Market Trends And Strategies

4. Precision Psychiatry Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Precision Psychiatry Growth Analysis And Strategic Analysis Framework

• 5.1. Global Precision Psychiatry PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Precision Psychiatry Market Growth Rate Analysis
• 5.4. Global Precision Psychiatry Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Precision Psychiatry Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Precision Psychiatry Total Addressable Market (TAM)

6. Precision Psychiatry Market Segmentation

• 6.1. Global Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacotherapy
• Psychotherapy
• Neurostimulation
• Digital Therapeutics
• Combination Therapies
• 6.2. Global Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing
• Biomarker Analysis
• Brain Imaging Techniques
• Wearable Devices
• Artificial Intelligence And Machine Learning Solutions
• 6.3. Global Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Depression
• Anxiety Disorders
• Bipolar Disorder
• Schizophrenia
• Post-Traumatic Stress Disorder (PTSD)
• 6.4. Global Precision Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Treatment
• Research
• 6.5. Global Precision Psychiatry Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Hospitals
• Research Institutes
• Pharmaceutical Companies
• Home Care Settings
• 6.6. Global Precision Psychiatry Market, Sub-Segmentation Of Pharmacotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antidepressant Medications
• Antipsychotic Medications
• Mood Stabilizers
• Anxiolytic Medications
• Stimulant Medications
• 6.7. Global Precision Psychiatry Market, Sub-Segmentation Of Psychotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Behavioral Therapy
• Interpersonal Therapy
• Psychodynamic Therapy
• Dialectical Behavior Therapy
• Mindfulness-Based Therapy
• 6.8. Global Precision Psychiatry Market, Sub-Segmentation Of Neurostimulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcranial Magnetic Stimulation
• Electroconvulsive Therapy
• Vagus Nerve Stimulation
• Deep Brain Stimulation
• Transcranial Direct Current Stimulation
• 6.9. Global Precision Psychiatry Market, Sub-Segmentation Of Digital Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile Application-Based Therapy
• Virtual Reality Therapy
• Web-Based Cognitive Behavioral Programs
• Remote Patient Monitoring Tools
• Artificial Intelligence-Guided Interventions
• 6.10. Global Precision Psychiatry Market, Sub-Segmentation Of Combination Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacotherapy And Psychotherapy Combination
• Pharmacotherapy And Neurostimulation Combination
• Pharmacotherapy And Digital Therapeutics Combination
• Psychotherapy And Neurostimulation Combination
• Multimodal Precision Treatment Programs

7. Precision Psychiatry Market Regional And Country Analysis

• 7.1. Global Precision Psychiatry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Precision Psychiatry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Precision Psychiatry Market

• 8.1. Asia-Pacific Precision Psychiatry Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Precision Psychiatry Market

• 9.1. China Precision Psychiatry Market Overview
• 9.2. China Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Precision Psychiatry Market

• 10.1. India Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Precision Psychiatry Market

• 11.1. Japan Precision Psychiatry Market Overview
• 11.2. Japan Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Precision Psychiatry Market

• 12.1. Australia Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Precision Psychiatry Market

• 13.1. Indonesia Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Precision Psychiatry Market

• 14.1. South Korea Precision Psychiatry Market Overview
• 14.2. South Korea Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Precision Psychiatry Market

• 15.1. Western Europe Precision Psychiatry Market Overview
• 15.2. Western Europe Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Precision Psychiatry Market

• 16.1. UK Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Precision Psychiatry Market

• 17.1. Germany Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Precision Psychiatry Market

• 18.1. France Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Precision Psychiatry Market

• 19.1. Italy Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Precision Psychiatry Market

• 20.1. Spain Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Precision Psychiatry Market

• 21.1. Eastern Europe Precision Psychiatry Market Overview
• 21.2. Eastern Europe Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Precision Psychiatry Market

• 22.1. Russia Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Precision Psychiatry Market

• 23.1. North America Precision Psychiatry Market Overview
• 23.2. North America Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Precision Psychiatry Market

• 24.1. USA Precision Psychiatry Market Overview
• 24.2. USA Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Precision Psychiatry Market

• 25.1. Canada Precision Psychiatry Market Overview
• 25.2. Canada Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Precision Psychiatry Market

• 26.1. South America Precision Psychiatry Market Overview
• 26.2. South America Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Precision Psychiatry Market

• 27.1. Brazil Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Precision Psychiatry Market

• 28.1. Middle East Precision Psychiatry Market Overview
• 28.2. Middle East Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Precision Psychiatry Market

• 29.1. Africa Precision Psychiatry Market Overview
• 29.2. Africa Precision Psychiatry Market, Segmentation By Therapeutic Approaches, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Precision Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Precision Psychiatry Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Precision Psychiatry Market Competitive Landscape And Company Profiles

• 30.1. Precision Psychiatry Market Competitive Landscape
• 30.2. Precision Psychiatry Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Precision Psychiatry Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Bristol-Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. Eli Lilly and Company
• 31.5. Otsuka Pharmaceutical Company Limited
• 31.6. Laboratory Corporation of America Holdings
• 31.7. Quest Diagnostics Incorporated
• 31.8. Illumina Inc.
• 31.9. ARUP Laboratories Inc.
• 31.10. Sumitomo Dainippon Pharma Company Limited
• 31.11. QIAGEN N.V.
• 31.12. Neurocrine Biosciences Inc.
• 31.13. Tempus Labs Inc.
• 31.14. Myriad Genetics Inc.
• 31.15. MedGenome Labs Ltd.

32. Global Precision Psychiatry Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Precision Psychiatry Market

34. Recent Developments In The Precision Psychiatry Market

35. Precision Psychiatry Market High Potential Countries, Segments and Strategies

• 35.1 Precision Psychiatry Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Precision Psychiatry Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Precision Psychiatry Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer